Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PHATHOM PHARMACEUTICALS INC.
PHAT | US
11.11
USD0.44
4.12%
PHAT | US
Loading StockChartView...
About PHATHOM PHARMACEUTICALS INC.
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
11.11
Open
10.50
High
11.21
Low
10.33
Phathom Pharmaceuticals Inc. biopharmaceutical company focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States Europe and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals Inc. was incorporated in 2018 and is headquartered in Florham Park New Jersey.
View LessPHAT | US
Risk
76.6
Sharpe
0.65
Luna's Score
45/100
Recommendation
Sell
Luna says (PHAT | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
What's not Working
Price Below SMA10D
High Short-term Volatility
Smallcap (300M - 2B USD)
High Short percentage (> 15%)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
88.8%1 month
76.6%3 months
71.6%6 months
62.4%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
25.37
Debt to equity
-2.17
Debt to assets
1.59
Ent. to EBITDA
-2.20
Ent. to rev.
101.64
PEG
-
Other Fundamentals
EBITDA
-252.07M
MarketCap
758.70M
MarketCap(USD)
758.70M
Div. yield
-
Op. margin
-1.06K
Erngs. growth
-
Rev. growth
-
Ret. on equity
-3.49K
Short ratio
15.37
Short perc.
35.61
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
4.22
Range1M
4.22
Range3M
8.14
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.66
Price X volume
7.57M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.20 | 0.53 | Cheaper |
| Ent. to Revenue | 101.64 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 25.37 | 15.55 | Expensive |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 71.62 | 72.80 | Par |
| Debt to Equity | -2.17 | -1.23 | Cheaper |
| Debt to Assets | 1.59 | 0.25 | Expensive |
| Market Cap | 758.70M | 3.66B | Emerging |
